Kidney Research UK with David J P Henderson, Head of Biology

Last week, David J P Henderson, our Head of Biology, represented Mironid at Kidney Research UK’s Driving Discoveries Conference in Bristol, where he provided an update on our LoAc molecule and its potential as a treatment option for ADPKD.

The conference provided an excellent platform to engage with leading experts in the kidney disease community, exchange insights, and learn about the latest research driving innovation toward improving the lives of patients.

Thank you to Kidney Research UK for hosting such an insightful event!

Find out more about what we do here: https://mironid.com/

The Latest

Mironid Raises Awareness for PKD with 1,000 km Team ChallengeApril 14, 2026

At Mironid, we’re proud to support causes that make a meaningful difference. Last month, our team took part in the Polycystic Kidney Disease (PKD) Charity UK‘s ‘Spring into March’ challenge, raising awareness and supporting the [...]

Q&A with David Henderson, Head of BiologyMarch 19, 2026

ADPKD is a devastating disease that affects more than 12 million people worldwide. Over the past decade, there has been important progress in our understanding of the disease, with meaningful steps forward for both patients and clinicians. However, significant challenges remain. Tolerability [...]

Allosteric modulation of long-form PDE4 enzymes, a novel disease modifying treatment for Autosomal Dominant Polycystic Kidney DiseaseFebruary 18, 2026

Our Chief Scientific Officer, Adele Rowley, will be in London on 18 February for this year’s Ace Drug Discovery Summit, where she will be giving a presentation titled “Allosteric modulation of long-form PDE4 enzymes, a [...]